(Fundação de Amparo à Pesquisa do Estado de São Paulo) Therapy used against grade four glioblastoma multiforme combines a photoactive molecule and a chemotherapeutic agent — both encapsulated in protein-lipid nanoparticles; work was presented by Antônio Claudio Tedesco during FAPESP Week France.
Original source: https://www.eurekalert.org/pub_releases/2019-11/fda-nsf112719.php